- GLP-1 Receptor Agonist Study Confirms Past Trials, Adds Benefits and Risks Inside Precision Medicine
- Obesity drugs: huge study highlights new health risks Nature.com
- Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking study The Times of India
- GLP-1 Medications: A dual impact on health benefits and side effects The Economic Times
- Diabetes and Obesity Drugs Study Points to Effectiveness in Curbing Addictions Bloomberg
GLP-1 Receptor Agonist Study Confirms Past Trials, Adds Benefits and Risks Inside Precision MedicineObesity drugs: huge study highlights new health risks Nature.comNot just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking study The Times of IndiaGLP-1 Medications: A dual impact on health benefits and side effects The Economic TimesDiabetes and Obesity Drugs Study Points to Effectiveness in Curbing Addictions Bloomberg Top stories – Google News
